Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian Howe

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Lancet (London, England)|October 7, 2004
AD2000: design and conclusionsIan Howe
International Journal of Geriatric Psychiatry|April 27, 2005
Switching from donepezil to galantamine: a double-blind study of two wash-out periodsDavid G Wilkinson, Ian Howe
Drugs & Aging|July 24, 2003
A long-term comparison of galantamine and donepezil in the treatment of Alzheimer's diseaseGordon Wilcock, Ian Howe, Hilary Coles, et al.
JAMA|September 9, 2004
Effect of galantamine hydrobromide in chronic fatigue syndrome: a randomized controlled trialC V Russell Blacker, David T Greenwood, Keith A Wesnes, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Lancet (London, England)|October 7, 2004
AD2000: design and conclusionsIan Howe
International Journal of Geriatric Psychiatry|April 27, 2005
Switching from donepezil to galantamine: a double-blind study of two wash-out periodsDavid G Wilkinson, Ian Howe
Drugs & Aging|July 24, 2003
A long-term comparison of galantamine and donepezil in the treatment of Alzheimer's diseaseGordon Wilcock, Ian Howe, Hilary Coles, et al.
JAMA|September 9, 2004
Effect of galantamine hydrobromide in chronic fatigue syndrome: a randomized controlled trialC V Russell Blacker, David T Greenwood, Keith A Wesnes, et al.
Pageof 1